Rakuten Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Rakuten Investment Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.9M	Buy	21,260 +2,257	+12%	+$1.73M	0.03%	106
2025 Q4	$14.8M	Sell	19,003 -39,903	-68%	-$27.1M	0.05%	114
2025 Q3	$4.89M	Buy	+58,906	New	+$33.3M	0.02%	253
2025 Q1	$8.68M	Buy	+13,622	New	+$9.37M	0.04%	124
2024 Q3	$8.88M	Buy	8,520 +2,199	+35%	+$2.45M	0.05%	69
2024 Q2	$6.64M	Buy	6,321 +2,432	+63%	+$2.36M	0.04%	67
2024 Q1	$3.74M	Buy	3,889 +3,624	+1,368%	+$3.45M	0.03%	74
2023 Q4	$234K	Buy	+265	New	+$218K	﹤0.01%	100

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Rakuten Investment Management's REGN Position: Q1 2026 in Review

Rakuten Investment Management increased its Regeneron Pharmaceuticals (REGN) stake by 12% in Q1 2026, buying an estimated $1.73M and bringing the position to 21,260 shares worth $15.9M. The position accounts for 0.03% of the portfolio, ranked #106.

Rakuten Investment Management first reported a position in REGN in Q4 2023 and has held it in 8 quarters since. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

Rakuten Investment Management held 21,260 shares of Regeneron Pharmaceuticals worth $15.9M as of Q1 2026.
Rakuten Investment Management bought 2,257 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $1.73M.
Regeneron Pharmaceuticals made up 0.03% of Rakuten Investment Management's portfolio in Q1 2026, its #106 holding.
Rakuten Investment Management first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Rakuten Investment Management's 13F filing for Q1 2026, filed 12 May 2026.